Sanara MedTech Inc. Common Stock (SMTI)
Sanara MedTech Inc. is a medical technology company focused on developing, manufacturing, and marketing innovative products for wound care, regenerative medicine, and surgical applications. The company aims to improve patient outcomes through its portfolio of advanced medical solutions, emphasizing minimally invasive procedures and advanced healing technologies.
Company News
Sanara MedTech reported Q2 2025 earnings with 28% revenue growth, driven by surgical segment performance. The company's value-based care segment (Tissue Health Plus) continues to face challenges, prompting a strategic review.
Biomimetic Innovations Ltd, an affiliate of PBC Biomed, has announced an exclusive license and distribution agreement with Sanara MedTech Inc. for the company's OsStic® Synthetic Injectable Structural Bio-Adhesive Bone Void Filler. Sanara has also made a minority investment in Biomimetic Innovations Ltd.
The heavy selling pressure might have exhausted for Sanara MedTech Inc. (SMTI) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.